GlassScriptPhysician profile
Kunal Brahmbhatt
NPI 1083059158
$13,647.00
in general payments reported to CMS, 2019-2025
36 companies · $1,503 in 2025
The $1,503 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $898 · 2020: $2,370 · 2021: $355 · 2022: $1,976 · 2023: $3,767 · 2024: $2,779 · 2025: $1,503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,883 · Travel and Lodging: $1,066 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,882.73 |
| Travel and Lodging | $1,065.72 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,333.33 | 2022-2025 | Impella |
| Medtronic Vascular, INC. | $1,920.45 | 2020 | |
| Medtronic, INC. | $1,539.31 | 2022-2025 | Corevalve Evolut R, Hawkone, Symplicity G3 |
| Penumbra, INC. | $1,055.95 | 2020-2023 | Indigo System |
| Edwards Lifesciences Corporation | $956.62 | 2019-2020 | |
| Abbott Laboratories | $944.02 | 2022-2025 | Esprit, Cardiomems, Navitor |
| Cardiovascular Systems INC. | $651.08 | 2021-2022 | |
| Shockwave Medical, INC | $562.49 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bard Peripheral Vascular, INC. | $425.80 | 2022-2024 | Crosser Iq |
| Merck Sharp & Dohme LLC | $387.90 | 2021-2025 | Verquvo, Steglatro |
| Angiodynamics, INC. | $349.40 | 2021-2023 | Auryon Laser System 100-120 Vac |
| Amgen INC. | $339.23 | 2020-2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $338.41 | 2021-2024 | |
| Biotronik INC. | $258.48 | 2022-2025 | Biomonitor |
| Boston Scientific Corporation | $241.47 | 2022-2024 | Avvigo Guidance System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $207.05 | 2020-2023 | Brilinta, Farxiga |
| Inari Medical, INC. | $189.05 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $146.24 | 2020 | |
| Corcept Therapeutics | $124.99 | 2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $99.68 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $95.87 | 2020-2025 | Camzyos, Eliquis |
| Cordis US Corp. | $75.00 | 2023 | Mynx Control |
| Pfizer INC. | $50.96 | 2021-2025 | |
| Cleerly, INC. | $46.78 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Acist Medical Systems, INC. | $46.44 | 2024 | |
| Atricure, INC. | $40.12 | 2021 | |
| Chiesi USA, INC. | $35.44 | 2020 | |
| Novo Nordisk INC | $34.62 | 2025 | Wegovy |
| Philips North America LLC | $33.34 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.29 | 2020 | |
| Heartflow, INC. | $20.66 | 2024 | |
| Cook Medical LLC | $17.32 | 2023 | Zilver Vena |
| Amarin Pharma, INC. | $14.55 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.34 | 2023 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $14.31 | 2024 | Arcalyst |
| Siemens Medical Solutions USA, INC. | $13.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunal Brahmbhatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.